PG 7.02 BCL-2: a new therapeutic target in estrogen receptor-positive breast cancer?. (March 2015) - Lindeman, G.J.; Merino, D.; Vaillant, F.; Lok, S.W.; Shackleton, K.; Visvader, J.E.